Therapeutic Advances in Pediatric Multiple Sclerosis

Pediatric-onset multiple sclerosis (POMS) is a chronic, immune-mediated disorder that affects the central nervous system in children and adolescents. Approximately 3–10% of MS patients have an onset that occurs before the age of 18. The vast majority of pediatric MS cases are characterized by a rela...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Children (Basel) Jg. 12; H. 3; S. 259
Hauptverfasser:	Walsh, Rachel, Chitnis, Tanuja
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 20.02.2025 MDPI
Schlagworte:	B cells Children Clinical trials Development and progression Disease disease-modifying therapy Diseases EDSS Immunomodulators Induction therapy Interferon Multiple sclerosis Ofatumumab Pathogenesis Patients pediatric multiple sclerosis pediatric-onset multiple sclerosis (POMS) Pediatrics PIRA RAW Review United States Italy Mississippi RAW pediatric multiple sclerosis pediatric-onset multiple sclerosis (POMS) PIRA disease-modifying therapy EDSS
ISSN:	2227-9067, 2227-9067
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!